metabion introduces updated DNA portfolio
Expands with DNA Longmers, therapeutic modifications, new options like MEX, Atto 700, 2′-MOE, and reintroduces BHQ-3®, IRDye® 700.
See the latest news and media coverage for metabion. We track all announcements, press releases, and industry mentions in real time, all in one place.
Custom oligonucleotide synthesis provider
metabion.comLast updated
In short: metabion expanded its DNA portfolio, increased production capacity in Munich, and formed strategic partnerships to support therapeutic development.
Expands with DNA Longmers, therapeutic modifications, new options like MEX, Atto 700, 2′-MOE, and reintroduces BHQ-3®, IRDye® 700.
They combine oligo synthesis and click-chemistry expertise to streamline targeted therapeutic oligonucleotide development.
They collaborate to provide seamless supply of custom GMP grade oligonucleotides from research to commercialization, ensuring continuity and reliability.
The collaboration ensures seamless supply of custom GMP grade therapeutic oligonucleotides from research to commercialization. It supports innovators in the oligo therapeutic market worldwide.
Germany-based metabion says it increased its global production capacity for diagnostic and newly introduced therapeutic oligonucleotides and derivatives to support the rising demand in Europe...
metabion is a globally leading supplier of Custom Nucleic Acids renowned for its focus on reliable supplies of consistently high ...
Cationic oligos reportedly offer inherent chemical advantages for molecular biology. Custom nucleic acids company Metabion negotiated a license to manufacture and commercialize Polyplus-transfection's Zip Nucleic...
Track metabion and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to metabion and other trending companies.